1. Home
  2. NVCR vs KW Comparison

NVCR vs KW Comparison

Compare NVCR & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • KW
  • Stock Information
  • Founded
  • NVCR 2000
  • KW 1977
  • Country
  • NVCR Jersey
  • KW United States
  • Employees
  • NVCR N/A
  • KW N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • KW Real Estate
  • Sector
  • NVCR Health Care
  • KW Finance
  • Exchange
  • NVCR Nasdaq
  • KW Nasdaq
  • Market Cap
  • NVCR 1.8B
  • KW 1.5B
  • IPO Year
  • NVCR 2015
  • KW 1992
  • Fundamental
  • Price
  • NVCR $17.09
  • KW $10.98
  • Analyst Decision
  • NVCR Buy
  • KW Hold
  • Analyst Count
  • NVCR 5
  • KW 1
  • Target Price
  • NVCR $26.60
  • KW $13.00
  • AVG Volume (30 Days)
  • NVCR 885.3K
  • KW 497.1K
  • Earning Date
  • NVCR 10-30-2024
  • KW 11-06-2024
  • Dividend Yield
  • NVCR N/A
  • KW 4.32%
  • EPS Growth
  • NVCR N/A
  • KW N/A
  • EPS
  • NVCR N/A
  • KW N/A
  • Revenue
  • NVCR $577,738,000.00
  • KW $483,200,000.00
  • Revenue This Year
  • NVCR $19.13
  • KW N/A
  • Revenue Next Year
  • NVCR $5.33
  • KW N/A
  • P/E Ratio
  • NVCR N/A
  • KW N/A
  • Revenue Growth
  • NVCR 14.63
  • KW N/A
  • 52 Week Low
  • NVCR $11.29
  • KW $7.85
  • 52 Week High
  • NVCR $24.74
  • KW $13.27
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 52.30
  • KW 49.11
  • Support Level
  • NVCR $15.35
  • KW $10.67
  • Resistance Level
  • NVCR $17.35
  • KW $11.81
  • Average True Range (ATR)
  • NVCR 0.98
  • KW 0.37
  • MACD
  • NVCR -0.06
  • KW -0.03
  • Stochastic Oscillator
  • NVCR 52.41
  • KW 27.02

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

Share on Social Networks: